Bahamondez-Canas TF - Search Results

1

Development, Characterization, and In Vitro Testing of Co-Delivered Antimicrobial Dry Powder Formulation for the Treatment of Pseudomonas aeruginosa Biofilms.

Bahamondez-Canas TF, Ferrati S, Moraga-Espinoza DF, Smyth HDC. Bahamondez-Canas TF, et al. J Pharm Sci. 2018 Aug;107(8):2172-2178. doi: 10.1016/j.xphs.2018.04.015. Epub 2018 Apr 24. J Pharm Sci. 2018. PMID: 29698726

2

Influence of Excipients on the Antimicrobial Activity of Tobramycin Against Pseudomonas aeruginosa Biofilms.

Bahamondez-Canas T, Smyth HDC. Bahamondez-Canas T, et al. Pharm Res. 2018 Jan 2;35(1):10. doi: 10.1007/s11095-017-2301-5. Pharm Res. 2018. PMID: 29294187

3

PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.

Bahamondez-Canas TF, Zhang H, Tewes F, Leal J, Smyth HDC. Bahamondez-Canas TF, et al. Mol Pharm. 2018 Apr 2;15(4):1643-1652. doi: 10.1021/acs.molpharmaceut.8b00011. Epub 2018 Mar 13. Mol Pharm. 2018. PMID: 29514003

4

PEGylated Chitosan for Nonviral Aerosol and Mucosal Delivery of the CRISPR/Cas9 System in Vitro.

Zhang H, Bahamondez-Canas TF, Zhang Y, Leal J, Smyth HDC. Zhang H, et al. Among authors: bahamondez canas tf. Mol Pharm. 2018 Nov 5;15(11):4814-4826. doi: 10.1021/acs.molpharmaceut.8b00434. Epub 2018 Oct 1. Mol Pharm. 2018. PMID: 30222933 Free PMC article.

5

Current Status of In Vitro Models and Assays for Susceptibility Testing for Wound Biofilm Infections.

Bahamondez-Canas TF, Heersema LA, Smyth HDC. Bahamondez-Canas TF, et al. Biomedicines. 2019 Apr 30;7(2):34. doi: 10.3390/biomedicines7020034. Biomedicines. 2019. PMID: 31052271 Free PMC article. Review.

6

Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms.

Tewes F, Bahamondez-Canas TF, Smyth HDC. Tewes F, et al. Among authors: bahamondez canas tf. AAPS PharmSciTech. 2019 May 29;20(5):205. doi: 10.1208/s12249-019-1417-9. AAPS PharmSciTech. 2019. PMID: 31144198

7

In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa.

Tewes F, Bahamondez-Canas TF, Moraga-Espinoza D, Smyth HDC, Watts AB. Tewes F, et al. Among authors: bahamondez canas tf. Eur J Pharm Biopharm. 2020 Jul;152:210-217. doi: 10.1016/j.ejpb.2020.05.014. Epub 2020 May 20. Eur J Pharm Biopharm. 2020. PMID: 32442738 Free article.

8

Innovating on Inhaled Bioequivalence: A Critical Analysis of the Current Limitations, Potential Solutions and Stakeholders of the Process.

Gallegos-Catalán J, Warnken Z, Bahamondez-Canas TF, Moraga-Espinoza D. Gallegos-Catalán J, et al. Among authors: bahamondez canas tf. Pharmaceutics. 2021 Jul 9;13(7):1051. doi: 10.3390/pharmaceutics13071051. Pharmaceutics. 2021. PMID: 34371741 Free PMC article. Review.

9

The forgotten material: Highly dispersible and swellable gelatin-based microspheres for pulmonary drug delivery of cromolyn sodium and ipratropium bromide.

Behrend-Keim B, Castro-Muñoz A, Monrreal-Ortega L, Ávalos-León B, Campos-Estrada C, Smyth HDC, Bahamondez-Canas TF, Moraga-Espinoza D. Behrend-Keim B, et al. Among authors: bahamondez canas tf. Int J Pharm. 2023 Sep 25;644:123331. doi: 10.1016/j.ijpharm.2023.123331. Epub 2023 Aug 18. Int J Pharm. 2023. PMID: 37597595

10

Intranasal immunization with dry powder vaccines.

Bahamondez-Canas TF, Cui Z. Bahamondez-Canas TF, et al. Eur J Pharm Biopharm. 2018 Jan;122:167-175. doi: 10.1016/j.ejpb.2017.11.001. Epub 2017 Nov 6. Eur J Pharm Biopharm. 2018. PMID: 29122735 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters